© 2016 Elsevier Ltd Purpose Severe fatigue after treatment of ductal carcinoma in situ (DCIS) has not been studied before. The current study examined (i) the prevalence of severe fatigue in DCIS patients versus breast cancer survivors (BCS) and healthy controls (HC), (ii) quality of life and functioning of severely versus non-severely fatigued DCIS patients and BCS, and (iii) the association of fatigue with psychosocial and behavioral factors in DCIS patients. Methods 89 patients treated for DCIS were matched on age and gender to 67 BCS and 178 HC (ratio 1:1:2). Fatigue was measured with the Fatigue Severity subscale of the Checklist Individual Strength. Results 23% of DCIS patients, 25% of BCS, and 6% of HC were severely fatigued (DCIS ver...
AbstractPurposeTo determine the prevalence of cancer-related fatigue syndrome (CRFS) in a population...
Background Fatigue is the most common and persistent symptom among women in the first five years aft...
OBJECTIVE: Fatigue is among the most distressing symptoms across the breast cancer continuum. Howeve...
Severe fatigue after treatment of ductal carcinoma in situ (DCIS) has not been studied before. The c...
OBJECTIVE: Fatigue is investigated in 57 severely fatigued disease-free breast cancer patients and i...
Objective: The aims of this study were to estimate the prevalence of severe fatigue in disease-fre...
Simple Summary The number of long-term breast cancer survivors is increasing. Earlier research showe...
BACKGROUND: We investigated whether fatigue is a persistent problem, and whether persistent fatigue ...
Introduction. Fatigue is the most common and stressful side effect of cancer and its treatments and ...
Purpose: Prolonged and disabling fatigue is prevalent after cancer treatment, but the early natural ...
Severe fatigue occurs in one in four breast cancer survivors (BCS). Quality of life (QOL) and psycho...
The present thesis consists of 1 literature review and 6 research articles on the subject of fatigue...
INTRODUCTION: Fatigue is a frequent problem during and after cancer treatment. We investigated diffe...
This meta-analysis aimed to (i) examine demographic, disease-related, and treatment-related risk fac...
BackgroundFatigue is a common and expected side effect of cancer treatment. However, the majority of...
AbstractPurposeTo determine the prevalence of cancer-related fatigue syndrome (CRFS) in a population...
Background Fatigue is the most common and persistent symptom among women in the first five years aft...
OBJECTIVE: Fatigue is among the most distressing symptoms across the breast cancer continuum. Howeve...
Severe fatigue after treatment of ductal carcinoma in situ (DCIS) has not been studied before. The c...
OBJECTIVE: Fatigue is investigated in 57 severely fatigued disease-free breast cancer patients and i...
Objective: The aims of this study were to estimate the prevalence of severe fatigue in disease-fre...
Simple Summary The number of long-term breast cancer survivors is increasing. Earlier research showe...
BACKGROUND: We investigated whether fatigue is a persistent problem, and whether persistent fatigue ...
Introduction. Fatigue is the most common and stressful side effect of cancer and its treatments and ...
Purpose: Prolonged and disabling fatigue is prevalent after cancer treatment, but the early natural ...
Severe fatigue occurs in one in four breast cancer survivors (BCS). Quality of life (QOL) and psycho...
The present thesis consists of 1 literature review and 6 research articles on the subject of fatigue...
INTRODUCTION: Fatigue is a frequent problem during and after cancer treatment. We investigated diffe...
This meta-analysis aimed to (i) examine demographic, disease-related, and treatment-related risk fac...
BackgroundFatigue is a common and expected side effect of cancer treatment. However, the majority of...
AbstractPurposeTo determine the prevalence of cancer-related fatigue syndrome (CRFS) in a population...
Background Fatigue is the most common and persistent symptom among women in the first five years aft...
OBJECTIVE: Fatigue is among the most distressing symptoms across the breast cancer continuum. Howeve...